Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adverum Biotechnologies, Inc. - Common Stock (NQ: ADVM )

2.980 +0.130 (+4.56%)
Streaming Delayed Price Updated: 12:28 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 453,790
Open 2.870
Bid (Size) 2.970 (5)
Ask (Size) 2.990 (1)
Prev. Close 2.850
Today's Range 2.850 - 3.110
52wk Range 2.715 - 11.87
Shares Outstanding 98,125,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-37.92%
-37.92%
1 Month
-44.81%
-44.81%
3 Month
-33.33%
-33.33%
6 Month
-63.30%
-63.30%
1 Year
-72.91%
-72.91%

More News

Read More
Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
From Pomerantz LLP
Via GlobeNewswire
Top movers in Wednesday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q2 2024
Via InvestorPlace
Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Adverum Releases Interim Data From Gene Therapy Study For Blindness Disorder, Prepares For Pivotal Study
Via Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Misses EPS for Q1 2024
Via InvestorPlace
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q4 2023
Via InvestorPlace
Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop
Via InvestorPlace
Stocks on the Launchpad: The Next 3 Market Sensations
Via InvestorPlace
Unleash Massive Returns With These 3 Top Penny Stocks
Via InvestorPlace
Topics Economy
Exposures Economy
Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?
Via Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.